Juventas Therapeutics

Juventas Therapeutics is a privately-held, clinical-stage biotechnology company developing a pipeline of regenerative therapies for life-threatening diseases. Founded in 2007, Juventas holds an exclusive license from the Cleveland Clinic and has advanced its therapeutic platform from concept to early-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received non-dilutive grant support through Ohio Third Frontier funding, Cleveland Clinic’s Ohio BioValidation Fund, the Global Cardiovascular Innovation Center, and the Center for Stem Cell and Regenerative Medicine.